Literature DB >> 11991870

New treatments for pulmonary arterial hypertension.

Marius M Hoeper1, Nazzareno Galiè, Gerald Simonneau, Lewis J Rubin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11991870     DOI： 10.1164/rccm.200110-028PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

Review 1.  [Lung transplantation. Possibilities and limitations].

Authors:  J Gottlieb; T Welte; M M Höper; M Strüber; J Niedermeyer
Journal:  Internist (Berl)       Date:  2004-11       Impact factor: 0.743

Review 2.  [Medicinal vasoactive therapy of microcirculation disorders in rheumatoid arthritis].

Authors:  G Riemekasten; H Schulze-Koops
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

3.  Ebstein's anomaly with an atrial septal defect in a jindo dog.

Authors:  Ran Choi; Seung-Keun Lee; Hyeong-Sun Moon; In-Chul Park; Changbaig Hyun
Journal:  Can Vet J       Date:  2009-04       Impact factor: 1.008

Review 4.  A review of pulmonary arterial hypertension: Part 2: Current and expected treatments.

Authors:  C T Gan; A Vonk Noordegraaf; K M J Marques; J G F Bronzwaer; P E Postmus; A Boonstra
Journal:  Neth Heart J       Date:  2004-08       Impact factor: 2.380

Review 5.  Drug treatment of pulmonary arterial hypertension: current and future agents.

Authors:  Marius M Hoeper
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  [Pulmonary hypertension: pathophysiology, genetics and functional genomics].

Authors:  O Eickelberg; W Seeger
Journal:  Internist (Berl)       Date:  2005-07       Impact factor: 0.743

Review 7.  Sildenafil for the treatment of pulmonary hypertension in pediatric patients.

Authors:  Alice J Huddleston; Chad A Knoderer; Jennifer L Morris; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

Review 8.  Pulmonary manifestations of sickle cell disease.

Authors:  A K Siddiqui; S Ahmed
Journal:  Postgrad Med J       Date:  2003-07       Impact factor: 2.401

9.  Nitric oxide donors inhibit 5-hydroxytryptamine (5-HT) uptake by the human 5-HT transporter (SERT).

Authors:  Lesley J Bryan-Lluka; Marisa H Papacostas; Filip A Paczkowski; Janet C Wanstall
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

10.  Integrated care and optimal management of pulmonary arterial hypertension.

Authors:  Geoff Strange; Robin Fowler; Corina Jary; Brad Dalton; Simon Stewart; Eli Gabbay
Journal:  J Multidiscip Healthc       Date:  2009-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.